Pramipexole Treatment Report
See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Mirapex, Mirapexin, Novo-Pramipexole, Pexola, r(+) pramipexole, Sifrol
Generic Name: Pramipexole
See also:
Research Study KNS-760704
What is Pramipexole?
Pramipexole has similar effects of dopamine, a naturally occurring chemical in the body. Low levels of dopamine are associated with Parkinson's disease (PD). It is used to treat PD symptoms, such as stiffness, tremors, muscle spasms, and poor muscle control; also used to treat restless legs syndrome
Read more...
See more information, including instructions, precautions, side effects, and interactions.
Reasons Taken
449 patients in the community are taking or have taken Pramipexole.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Treat Parkinson's | 318 | 70% |
| Other | 51 | 11% |
| Stiffness/spasticity | 19 | 4% |
| Slowness | 8 | 1% |
| disease-related symptoms | 6 | 1% |
| Slow my ALS progress | 5 | 1% |
| Restless Leg Syndrome | 5 | 1% |
| Don't know | 3 | <1% |
| Fatigue | 3 | <1% |
| Depression | 2 | <1% |
| General health | 2 | <1% |
| Fasciculations | 2 | <1% |
| Anxiety | 2 | <1% |
| Cramps, calf muscles | 1 | <1% |
| tremor | 1 | <1% |
| restless legs | 1 | <1% |
| Lack of motivation | 1 | <1% |
| tremor, hand | 1 | <1% |
| Tremor, left hand, wrist and arm | 1 | <1% |
| Insomnia | 1 | <1% |
| Muscle cramping, spasms | 1 | <1% |
| Mobility | 1 | <1% |
| Brandykinesia | 1 | <1% |
| Treat my mood condition(s) | 1 | <1% |
| Support another treatment | 1 | <1% |
| 0 mg day | 0 day | 0 mg none | 0.05 mg day | 0.0625 mg day | 0.1 mg day | 0.125 mg day | 0.25 mg day | 0.3 mg day | 0.375 mg day | 0 mg none | 0.5 mg day | 0.5 day | 0.75 mg day | 0 mg none | 1 mg day | 1 tbs. day | 1 day | 1.08 mg day | 1.125 mg day | 1.25 mg day | 1.4 mg day | 1.5 mg day | 1.5 day | 1.75 mg day | 2 mg day | 2 other day | 2.25 mg day | 2.5 mg day | 2.64 mcg day | 3 mg day | 3 day | 3.25 mg day | 3.5 mg day | 3.75 mg day | 3.75 day | 4 mg day | 4.25 mg day | 4.5 mg day | 5 mg day | 6 mg day | 6 mL day | 6 day | 6.5 mg day | 9 mg day | 10 mg day | 20 mg day | 25 mg day | 27.5 mg day | 50 day | 75 mg day | 100 mg day | 150 mg day | 200 mg day | 200 day | 225 mg day | 300 mg day | 500 mg day | 750 mg day | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9
|
6
|
3
|
2
|
1
|
1
|
6
|
13
|
1
|
11
|
1
|
18
|
1
|
14
|
1
|
21
|
1
|
2
|
1
|
1
|
2
|
1
|
39
|
1
|
1
|
13
|
1
|
12
|
4
|
1
|
45
|
2
|
1
|
2
|
4
|
1
|
16
|
1
|
35
|
4
|
10
|
2
|
1
|
1
|
1
|
1
|
2
|
3
|
1
|
1
|
4
|
1
|
1
|
1
|
1
|
1
|
5
|
1
|
1
|
||
Duration
How long current patients have been taking Pramipexole or how long patients were taking Pramipexole before stopping.
Currently taking Pramipexole
Stopped taking Pramipexole
Patient Reported Evaluations
Results from 47 patient evaluations. See the overall results and all individual evaluations.
Efficacy (Effect based on reason taken)
| Major | 23% | 8 |
|---|---|---|
| Moderate | 49% | 17 |
| Slight | 9% | 3 |
| None | 11% | 4 |
| Can't tell | 9% | 3 |
Treat Parkinson's
Side-effects (as an overall problem)
| Severe | 17% | 8 |
|---|---|---|
| Moderate | 32% | 15 |
| Mild | 19% | 9 |
| None | 32% | 15 |
Top reported side-effects include: drowisness, Weight gain, Insomnia
Summary results are based on 47 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Individual Patient Reported Evaluations (2 of 47)
-
- archaeologist
- Mouth/throat: none
- Arms: mild
- Chest: none
- Legs: mild
- See profile
-
by archaeologist
Aug 18, 2008
- EfficacyMajor
- Side-effectsNone
- Treat Parkinson's
- See full evaluation
-
0 helpful marks
-
- planton
- Mouth/throat: mild
- Arms: mild
- Chest: mild
- Legs: mild
- See profile
-
by planton
Aug 18, 2008
- EfficacyModerate
- Side-effectsMild
- Treat Parkinson's
- See full evaluation
-
0 helpful marks